Patents by Inventor Christoph Reinhard

Christoph Reinhard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10560691
    Abstract: A system including a processing device and an exchangeable camera connected thereto for detecting a machine-readable security feature of a valuable document. The system is calibrated by means of processing device correction data, which relate to characteristics of the processing device, and camera calibration data, which relate to the characteristics of the processing device and of the camera connected thereto. The camera includes a memory configured to store the processing device correction data and the camera calibration data relating to the System in which the calibration is carried out, and the processing device includes a memory configured to store the processing device correction data and the camera calibration data relating to the system in which operation for detecting a machine-readable security feature of the valuable document is carried out.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: February 11, 2020
    Assignee: CI Tech Sensors, AG
    Inventors: Christoph Reinhard, Mathias Zenger
  • Publication number: 20190238829
    Abstract: A system including a processing device and an exchangeable camera connected thereto for detecting a machine-readable security feature of a valuable document. The system is calibrated by means of processing device correction data, which relate to characteristics of the processing device, and camera calibration data, which relate to the characteristics of the processing device and of the camera connected thereto. The camera includes a memory configured to store the processing device correction data and the camera calibration data relating to the System in which the calibration is carried out, and the processing device includes a memory configured to store the processing device correction data and the camera calibration data relating to the system in which operation for detecting a machine-readable security feature of the valuable document is carried out.
    Type: Application
    Filed: December 18, 2018
    Publication date: August 1, 2019
    Inventors: Christoph Reinhard, Mathias Zenger
  • Publication number: 20190236883
    Abstract: A device for verifying a machine-readable security feature of a document of value, having: a transport device configured to transport the document on a transport plane, a radiation emitter that is arranged on a first flat side and emits radiation in the direction towards the first flat side, a sensor that is arranged on the first flat side and is configured to receive at least part of the luminescent radiation, a reflector arranged and configured on the second flat side-so as to at least partly reflect the luminescent radiation of the security feature of the document of value to the sensor, and an evaluation unit.
    Type: Application
    Filed: December 18, 2018
    Publication date: August 1, 2019
    Inventor: Christoph Reinhard
  • Publication number: 20150031743
    Abstract: Compositions incorporating small interfering ribonucleic acid (siRNA) and certain lipid-conjugated polyamide compound-based delivery vehicles that are particularly useful in the delivery siRNA and other polynucleotides to cells. Also, methods of making and using the compositions.
    Type: Application
    Filed: July 5, 2014
    Publication date: January 29, 2015
    Applicant: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
    Inventors: Timothy S. BURKOTH, Ann B. JEFFERSON, Christoph REINHARD, Ronald N ZUCKERMANN
  • Patent number: 8772255
    Abstract: Compositions incorporating small interfering ribonucleic acid (siRNA) and certain lipid-conjugated polyamide compound-based delivery vehicles that are particularly useful in the delivery siRNA and other polynucleotides to cells. Also, methods of making and using the compositions.
    Type: Grant
    Filed: March 21, 2008
    Date of Patent: July 8, 2014
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Timothy S. Burkoth, Anne B. Jefferson, Christoph Reinhard, Ronald N. Zuckermann
  • Publication number: 20130196314
    Abstract: A polynucleotide sequence as shown in SEQ ID NO:1 is associated with metastatic potential of cancer cells, especially breast cancer cells. Methods are provided for determining the risk of metastasis of a tumor, by determining whether a tissue sample from a tumor expresses a polypeptide or mRNA encoded by a polynucleotide as shown in SEQ ID NO:1. Also provided are therapeutic methods and compositions.
    Type: Application
    Filed: August 2, 2012
    Publication date: August 1, 2013
    Applicant: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Joerg Kaufmann, Greg Harrowe, Christoph Reinhard, Sanmao Kang
  • Patent number: 8472025
    Abstract: A device and a method for detecting reflected and/or emitted light of an object (1) are proposed having at least one illumination device (2) illuminating the object (1) with pulsed light, and having at least one sensor (4, 6) capturing the light reflected and/or emitted by the object (1), and having a transport device transporting the object relative to the illumination device (2) and past the sensor 4, 6) in the direction of transport, and having a power supply (16, 17, 18, 19, 20, 21, 22) for the illumination device (2) providing the illumination device (2) with a current that is a periodic function over time, wherein a period comprises at least two current pulses (23, 24) of different magnitudes.
    Type: Grant
    Filed: December 4, 2009
    Date of Patent: June 25, 2013
    Assignee: BEB Industrie-Elektronik AG
    Inventors: Christoph Reinhard, Reto Schletti
  • Publication number: 20120308569
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Application
    Filed: June 7, 2012
    Publication date: December 6, 2012
    Applicant: NOVARTIS VACCINES & DIAGNOSTICS, INC.
    Inventors: Vivien W. CHAN, Jaime Escobedo, Pablo Dominguez Garcia, Rhonda Hansen, Joerg Kaufmann, Giulia C. Kennedy, George Lamson, Edward J. Moler, Filippo Randazzo, Christoph Reinhard, Julie Sudduth-Klinger
  • Patent number: 8236928
    Abstract: A polynucleotide sequence as shown in SEQ ID NO:1 is associated with metastatic potential of cancer cells, especially breast cancer cells. Methods are provided for determining the risk of metastasis of a tumor, by determining whether a tissue sample from a tumor expresses a polypeptide or mRNA encoded by a polynucleotide as shown in SEQ ID NO:1. Also provided are therapeutic methods and compositions.
    Type: Grant
    Filed: June 8, 2006
    Date of Patent: August 7, 2012
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Joerg Kaufmann, Greg Harrowe, Christoph Reinhard, Sanmao Kang
  • Patent number: 8221983
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Grant
    Filed: March 16, 2010
    Date of Patent: July 17, 2012
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Vivien W. Chan, Jaime Escobedo, Pablo Dominguez Garcia, Rhonda Hansen, Joerg Kaufmann, Giulia C. Kennedy, George Lamson, Edward J. Moler, Filippo Randazzo, Christoph Reinhard, Julie Sudduth-Klinger
  • Publication number: 20110273717
    Abstract: A device and a method for detecting reflected and/or emitted light of an object (1) are proposed having at least one illumination device (2) illuminating the object (1) with pulsed light, and having at least one sensor (4, 6) capturing the light reflected and/or emitted by the object (1), and having a transport device transporting the object relative to the illumination device (2) and past the sensor 4, 6) in the direction of transport, and having a power supply (16, 17, 18, 19, 20, 21, 22) for the illumination device (2) providing the illumination device (2) with a current that is a periodic function over time, wherein a period comprises at least two current pulses (23, 24) of different magnitudes.
    Type: Application
    Filed: December 4, 2009
    Publication date: November 10, 2011
    Applicant: BEB INDUSTRIE-ELEKTRONIK AG
    Inventors: Christoph Reinhard, Reto Schletti
  • Patent number: 8012681
    Abstract: The invention provides, inter alia, models of bone metastasis, methods for identifying agents that modulate skeletal related events and metastasis, methods for modulating skeletal related events and metastases, and methods for detecting skeletal related events and metastases. The methods and models generally comprise co-culturing cancer cells and host cells and comparing biological markers from such co-cultured cells to control cells.
    Type: Grant
    Filed: May 12, 2004
    Date of Patent: September 6, 2011
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Deborah Lee Zimmerman, Rhonda Hansen, Jill Winter, Christoph Reinhard, Shuling Fang
  • Patent number: 7867731
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Grant
    Filed: October 28, 2004
    Date of Patent: January 11, 2011
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Christoph Reinhard, Anne Bennett Jefferson, Vivien W. Chan, Joerg Kaufmann, Hong Xin, Giulia C. Kennedy, Greg Harrowe, Hamiduddin Khoja, Venkatakrishna Shyamala
  • Patent number: 7855058
    Abstract: A human gene encoding a novel cyclin-dependent kinase termed hPNQALRE and its expression products can be used to provide reagents and methods for detecting neoplasia. Compositions and methods for treating proliferative disorders and neoplasia are also provided.
    Type: Grant
    Filed: June 7, 2007
    Date of Patent: December 21, 2010
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventor: Christoph Reinhard
  • Publication number: 20100233187
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Application
    Filed: March 16, 2010
    Publication date: September 16, 2010
    Inventors: Vivien W. Chan, Jaime Escobedo, Pablo Dominguez Garcia, Rhonda Hansen, Joerg Kaufmann, Giulia C. Kennedy, George Lamson, Edward J. Moler, Filippo Randazzo, Christoph Reinhard, Julie Sudduth-Klinger
  • Patent number: 7700359
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Grant
    Filed: September 22, 2004
    Date of Patent: April 20, 2010
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Vivien W. Chan, Jaime Escobedo, Pablo Dominguez Garcia, Rhonda Hansen, Joerg Kaufmann, Giulia C. Kennedy, George Lamson, Edward J. Moler, Filippo Randazzo, Christoph Reinhard, Julie Sudduth-Klinger
  • Publication number: 20090264506
    Abstract: The present invention provides a method for delivering polynucleotide agents, particularly oligonucleotides, to the CNS of a mammal by way of a neural pathway originating in the nasal cavity or through a neural pathway originating in an extranasal tissue that is innervated by the trigeminal nerve.
    Type: Application
    Filed: April 7, 2009
    Publication date: October 22, 2009
    Inventors: Christoph Reinhard, William H. Frey, II
  • Patent number: 7605246
    Abstract: A polynucleotide sequence as shown in SEQ ID NO:1 is associated with metastatic potential of cancer cells, especially breast cancer cells. Methods are provided for determining the risk of metastasis of a tumor, by determining whether a tissue sample from a tumor expresses a polypeptide or mRNA encoded by a polynucleotide as shown in SEQ ID NO:1. Also provided are therapeutic methods and compositions.
    Type: Grant
    Filed: January 9, 2001
    Date of Patent: October 20, 2009
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Joerg Kaufmann, Greg Harrowe, Christoph Reinhard, Sanmao Kang
  • Patent number: 7566559
    Abstract: A human gene encoding a novel cyclin-dependent kinase termed hPNQALRE and its expression products can be used to provide reagents and methods for detecting neoplasia. Compositions and methods for treating proliferative disorders and neoplasia are also provided.
    Type: Grant
    Filed: July 6, 2007
    Date of Patent: July 28, 2009
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventor: Christoph Reinhard
  • Publication number: 20090143322
    Abstract: Compositions incorporating small interfering ribonucleic acid (siRNA) and certain lipid-conjugated polyamide compound-based delivery vehicles that are particularly useful in the delivery siRNA and other polynucleotides to cells. Also, methods of making and using the compositions.
    Type: Application
    Filed: March 21, 2008
    Publication date: June 4, 2009
    Applicant: CHIRON CORPORATION
    Inventors: Timothy S. Burkoth, Anne B. Jefferson, Christoph Reinhard, Ronald N. Zuckermann
  • Patent number: 5167485
    Abstract: A joint connection for abutting, circumferentially extending segments in a gas turbine engine, such as turbine nozzle segments, includes a sealing member which is insertable between longitudinally extending slots formed in the abutting side edges of two adjacent segments. The segments are each formed with a number of grooves which are longitudinally spaced along the length of the slots therein, and which extend beneath the sealing member carried within the slots. A cooling air flow path is thus formed extending from one side of the sealing member, into the longitudinal slot of each segment and then through the grooves to the opposite side of the sealing member so that the entire joint connection or seal region between the abutting side edges of the segments is cooled.
    Type: Grant
    Filed: April 6, 1992
    Date of Patent: December 1, 1992
    Assignee: General Electric Company
    Inventor: John H. Starkweather